Literature DB >> 3530319

Crystal structure of a novel trimethoprim-resistant dihydrofolate reductase specified in Escherichia coli by R-plasmid R67.

D A Matthews, S L Smith, D P Baccanari, J J Burchall, S J Oatley, J Kraut.   

Abstract

Crystalline R67 dihydrofolate reductase (DHFR) is a dimeric molecule with two identical 78 amino acid subunits, each folded into a beta-barrel conformation. The outer surfaces of the three longest beta strands in each protomer together form a third beta barrel having six strands at the subunit interface. A unique feature of the enzyme structure is that while the intersubunit beta barrel is quite regular over most of its surface, an 8-A "gap" runs the full length of the barrel, disrupting potential hydrogen bonds between beta-strand D in subunit I and the adjacent corresponding strand of subunit II. It is proposed that this deep groove is the NADPH binding site and that the association between protein and cofactor is modulated by hydrogen-bonding interactions along one face of this antiparallel beta-barrel structure. A hypothetical model is proposed for the R67 DHFR-NADPH-folate ternary complex that is consistent with both the known reaction stereoselectivity and the weak binding of 2,4-diamino inhibitors to the plasmid-specified reductase. Geometrical comparison of this model with an experimentally determined structure for chicken DHFR suggests that chromosomal and type II R-plasmid specified enzymes may have independently evolved similar catalytic machinery for substrate reduction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530319     DOI: 10.1021/bi00363a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker.

Authors:  Jin Zhong; Michael Karberg; Alan M Lambowitz
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

2.  Effect of multiple symmetries on the association of R67 DHFR subunits bearing interfacial complementing mutations.

Authors:  Julie Dam; Arnaud Blondel
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

3.  Nobel lecture in physiology or medicine--1988. Selective inhibitors of dihydrofolate reductase.

Authors:  G H Hitchings
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

4.  Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin.

Authors:  M E Noble; A Musacchio; M Saraste; S A Courtneidge; R K Wierenga
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

5.  Asymmetric mutations in the tetrameric R67 dihydrofolate reductase reveal high tolerance to active-site substitutions.

Authors:  Maximilian C C J C Ebert; Krista L Morley; Jordan P Volpato; Andreea R Schmitzer; Joelle N Pelletier
Journal:  Protein Sci       Date:  2014-12-26       Impact factor: 6.725

Review 6.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

7.  Novel crystallization conditions for tandem variant R67 DHFR yield a wild-type crystal structure.

Authors:  Brahm J Yachnin; Damien Y Colin; Jordan P Volpato; Maximilian Ebert; Joelle N Pelletier; Albert M Berghuis
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-25

8.  Structure of the Q67H mutant of R67 dihydrofolate reductase-NADP+ complex reveals a novel cofactor binding mode.

Authors:  N Divya; E Grifith; Narendra Narayana
Journal:  Protein Sci       Date:  2007-05-01       Impact factor: 6.725

9.  Construction of a dihydrofolate reductase-deficient mutant of Escherichia coli by gene replacement.

Authors:  E E Howell; P G Foster; L M Foster
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

10.  Exploring the functional robustness of an enzyme by in vitro evolution.

Authors:  M A Martinez; V Pezo; P Marlière; S Wain-Hobson
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.